Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils.

Morrison TB, Weis JH, Weis JJ.

J Immunol. 1997 May 15;158(10):4838-45.

PMID:
9144499
2.
3.

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.

Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.

J Immunol. 2001 Jun 15;166(12):7398-403.

4.
5.

Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.

Pal U, de Silva AM, Montgomery RR, Fish D, Anguita J, Anderson JF, Lobet Y, Fikrig E.

J Clin Invest. 2000 Aug;106(4):561-9.

6.

Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.

Ding W, Huang X, Yang X, Dunn JJ, Luft BJ, Koide S, Lawson CL.

J Mol Biol. 2000 Oct 6;302(5):1153-64.

PMID:
11183781
9.

The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi.

Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R, Weis JJ.

J Immunol. 1998 Jun 1;160(11):5485-92.

10.
11.

Epitope mapping of the outer surface protein A (OspA) of the spirochete Borrelia burgdorferi using a panel of monoclonal antibodies and lanthanide competition fluoroimmunoassay.

Kharitonenkov IG, Pomelova VG, Bucher DJ, Cozzolino A, Bichenkova TA, Sadykbekova RK, Osin NS.

Biochemistry (Mosc). 2002 Jun;67(6):640-50.

PMID:
12126471
12.

Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.

Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.

Vaccine. 1997 Apr-May;15(6-7):739-46.

PMID:
9178476
13.

Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.

Molloy PJ, Berardi VP, Persing DH, Sigal LH.

Clin Infect Dis. 2000 Jul;31(1):42-7. Epub 2000 Jul 17.

PMID:
10913394
14.

Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.

Steere AC, Gross D, Meyer AL, Huber BT.

J Autoimmun. 2001 May;16(3):263-8. Review.

PMID:
11334491
15.

Interaction with Borrelia burgdorferi causes increased expression of the CR3 integrin and increased binding affinity to fibronectin via CR3.

Cinco M, Panfili E, Presani G, Perticarari S.

J Mol Microbiol Biotechnol. 2000 Oct;2(4):575-9.

PMID:
11075934
16.

Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.

Brunet LR, Katavolos P, Spielman A, Telford SR 3rd.

Med Vet Entomol. 1997 Apr;11(2):198-200. No abstract available.

PMID:
9226653
17.

Modification of Borrelia burgdorferi to overproduce OspA or VlsE alters its infectious behaviour.

Xu Q, McShan K, Liang FT.

Microbiology. 2008 Nov;154(Pt 11):3420-9. doi: 10.1099/mic.0.2008/019737-0.

PMID:
18957595
18.
19.
20.

Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis.

Vasiliu V, Herzer P, Rössler D, Lehnert G, Wilske B.

Med Microbiol Immunol. 1998 Oct;187(2):97-102.

PMID:
9832323

Supplemental Content

Support Center